Last news
Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI

Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI

...

Compass Offices Expands its Central Presence at China Building in Hong Kong

Compass Offices Expands its Central Presence at China Building in Hong Kong

...

Masterworks by René Magritte, Pablo Picasso, Jean-Michel Basquiat & Cecily Brown Unveiled in Asia for the First Time

Masterworks by René Magritte, Pablo Picasso, Jean-Michel Basquiat & Cecily Brown Unveiled in Asia for the First Time

...

IMAX China Nets 38 Million with The First Slam Dunk, Delivering Biggest Opening Weekend for A Foreign Animation Title

IMAX China Nets 38 Million with The First Slam Dunk, Delivering Biggest Opening Weekend for A Foreign Animation Title

...

Patsnap Unveils Synapse Visitor, the Latest AI-Powered Pharmaceutical Intelligence Platform

Patsnap Unveils Synapse Visitor, the Latest AI-Powered Pharmaceutical Intelligence Platform

...

Everest Medicines Launches Nefecon in China's Hainan Boao Pilot Zone as a First-in-Disease Therapy for IgA Nephropathy

Everest Medicines Launches Nefecon in China's Hainan Boao Pilot Zone as a First-in-Disease Therapy for IgA Nephropathy

...

Overwhelming number (96 percent) of channel partners in ANZ agree that cloud is key to 2023 strategy: Akamai Partner Survey

Overwhelming number (96 percent) of channel partners in ANZ agree that cloud is key to 2023 strategy: Akamai Partner Survey

...

Leading private equity firm SKS Capital invests in South Korea's Grace

Leading private equity firm SKS Capital invests in South Korea's Grace

...

menu
menu